Don't miss Asgard's Co-Founder & VP and Head of Research, Fabio Rosa, on The @biotechvoyager's live YouTube webcast this afternoon!
🎙️ It’s taking place at 11:30am EST / 4.30pm BST / /5.30pm CEST – so do tune in: https://t.co/5dqOWNZC5m
We hosted our 5th Annual Advisory Board Meeting in Lund last week, focusing on AT-108, our cell reprogramming cancer immunotherapy. 💫
We're pleased to also welcome Julie Cherrington, PhD, who brings decades of end-to-end drug development experience to our Advisory Board.
Fantastic to welcome @BiotechTV's @bradloncar to @AsgardThx' HQ in Lund! 📺 Watch the episode with our CEO @_CristianaPires to learn more about our cancer immunotherapy, AT-108, which triggers a personalized immune response despite being an off-the-shelf drug 👇
𝐅𝐫𝐨𝐦 𝐋𝐮𝐧𝐝: @AsgardThx aims to turn tumor cells into a type of dendritic cell inside the body with that the immune system can learn the tumor's signature and fight it systemically.
Full video: https://t.co/WVDsiEuI0C
✈️ @AsgardThx will be in Paris for the Intratumoral Immunotherapy Symposium 2026.
Catch the Asgard team to learn more about AT-108, our off‑the‑shelf immunotherapy designed to trigger a personalized anti‑tumor response.
#Oncology
🚨 We’re Hiring: In Vitro Laboratory Technician
🔬 Cell & molecular biology assays
🧪 Assay development
📊 Data analysis & reporting
Apply here: https://t.co/pJiQUavU6S
#Hiring#BiotechJobs#LaboratoryTechnician
Heading to Chicago for #ASCO2026?
Connect with Asgard’s CMO Wolfram Brugger and Senior Director Emma Leire to learn about our first-in-class, off-the-shelf, gene-based cancer immunotherapy, AT-108 🔬
Learn more: https://t.co/0GA5iUZjvn
#Oncology
Our Co-founder and CEO @_CristianaPires is joining a keynote panel session at the @LSX Leaders Nordic Congress! Don't miss it 👇
🎤 Oncology Spotlight: Advancing Cancer Care in the Nordics
🗓️ 20 May
🕐 13:00-13:40 CEST
📍 Norway/Finland Room, Radisson Blu Scandinavia Hotel
⏰ Asgard is presenting at #ASGCT2026! Our Co-founder & VP Research Fábio Rosa will deliver an oral presentation on AT-108 next week.
Connect with Fábio onsite if you're attending.
🗓 13 May | 4:30–4:45 PM
📌 Cancer Vaccines & Oncolytic Viruses
📍 Boston
#Cancer#GeneTherapy
Asgard will be giving an oral presentation at #CIMT2026!
🗓️ 12 May
🕥 10:30-12:00 CEST
📌 Short Talk Session 1: Cellular Therapy
🤝 Reach out to connect and discover Asgard's lead candidate, AT-108, which induces powerful, personalized anti-cancer responses.
🔬 @AsgardTx is presenting advanced preclinical data at #ASGCT2026! Data on AT-108, our first-in-class, off-the-shelf gene-based cancer immunotherapy, will be presented by Co-founder and VP & Head of Research, Fábio Rosa. Read the data highlights here 🔗 https://t.co/urR9qKui1p
Asgard is presenting at #BioEquity2026!
🗓️ 5 May | 11:15–11:30 CEST
📍 North Hall | Track 3
Connect with @_CristianaPires, Shane Olwill & Wolfram Brugger to learn more about AT‑108 and our latest milestones.
Asgard is joining a panel at the Cell and Gene Meeting on the Med 2026!
🎤 Engineering cells as medicines: the next generation of CGT platforms
📅 30 April, 11:00 – 12:00 CEST
Reach out to connect with @_CristianaPires and don't miss our company presentation on 28 April!
Asgard to present preclinical data on gene therapy AT-108 at the @AACR Annual Meeting 2026 in San Diego.
📅 22 April
🕘 9:00 AM - 12:00 PM PDT
🏢 Session: LBPO.ET04 - Late-Breaking Research: Experimental and Molecular Therapeutics 4
🔗 Full press release: https://t.co/Xz3kHJ6RTF
Our Co-founder and VP of Research, Fabio Rosa, received this year's @BioCPH & @ScienceMagazine Prize for Innovation! 🎉 Fabio reflects on how Asgard is reshaping the future of cancer immunotherapy in an article in Science: https://t.co/mibsCUSXLd
@BioCPH/ Esben Zøllner Olesen
📢 #AsgardTherapeutics welcomes Prof Dr Wolfram Brugger as CMO!
With experience across 130+ Phase I–III oncology trials, Wolfram brings deep clinical expertise that will be pivotal as we advance AT‑108 toward the clinic.
🔗 Full press release: https://t.co/N5d9XTZBiQ
🎉 Congratulations to Fábio Rosa, winner of the 2026 BioInnovation Institute & Science Prize for Innovation for his work in developing a novel cancer therapy that turns tumors into their own vaccines.
Learn more about the prize-winning work: https://t.co/PvcGzswac2
Our Co-founder and Head of Research Fabio Rosa has just been awarded the @BioCPH & @ScienceMagazine Prize for Innovation for his groundbreaking research in cancer cell reprogramming 👏 Huge congratulations! Read more: https://t.co/SZ9NBrmJrB
🎉 Congratulations to Fábio Rosa, winner of the 2026 BioInnovation Institute & Science Prize for Innovation for his work in developing a novel cancer therapy that turns tumors into their own vaccines.
Learn more about the prize-winning work: https://t.co/PvcGzswac2
Our CEO @_CristianaPires joined panels at #BIOEuropeSpring and the #LSXWorldCongress this week, exploring the art of saying no in strategic deal making and emerging modalities in drug development. Thanks to the industry leaders who joined Cristiana for these engaging discussions!
Asgard will be in Lisbon for #BIOEuropeSpring and #LSXWorldCongress 2026, with our Co-founder & CEO @_CristianaPires joining panels at both conferences! See details below to attend 👇
🤝 Want to arrange a meeting? Reach out via the official partnering platform to connect.
🚨 Hiring!
@AsgardThx is looking for an In Vivo Laboratory Technician
• in vivo mouse studies (syngeneic/CDX)
• tumor implantation, dosing (IT/IV/SC/IP), blood & tissue collection
• animal monitoring
• data reporting
📎 Apply: https://t.co/RkD0Bwlf1F
#Hiring#BiotechJobs